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Introduction: Alcohol use disorders represent one of the leading causes of preventable 
death, illness, and injury in many societies throughout the world. Heavy alcohol consumption 
has multiple negative consequences for people with epilepsy such as precipitation of seizure, 
exacerbation of seizure, poor seizure control, increased side effects of antiepileptic drugs, non-
compliance to antiepileptic drugs, alcohol withdrawal seizures, long-term hospital admission, 
status epilepticus, sudden unexpected death, and premature mortality.
Methods: An institution-based cross sectional study was conducted from April 15, 2014 to 
May 15, 2014 with the aim of assessing prevalence of alcohol use disorders and associated fac-
tors among people with epilepsy attending Amanuel Mental Specialized Hospital, Addis Ababa, 
Ethiopia. A total of 413 randomly selected epileptic patients were included in this study. Data 
were structured using the 10-item Alcohol Use Disorders Identification questionnaire. Data were 
analyzed using SPSS Version 20. Bivariate and multivariate logistic regression analyses were 
performed to study the association, and variables with P-value ,0.05 were considered as having 
a statistically significant association at 95% confidence interval.
Results: A total of 423 study participants were selected, of whom 413 completely filled the 
questionnaire making the response rate 97.6%. The mean age of the respondents was 31.9 years 
with standard deviation of ±10.97, and 248 (60%) were males. The prevalence of alcohol 
use disorder was 17.4%. Educational status (grade 9–12) (adjusted odds ratio [AOR] =3.25, 
[1.21, 8.69]), not living with family members (AOR =1.89, [1.06, 3.39]), availability of house 
(AOR =2.04, [1.10, 3.78]), taking carbamazepine (AOR =2.38, [1.13, 5.01]), and drinking 
alcohol to find relief from stress (AOR =4.28, [1.89, 9.67]) were significantly associated with 
alcohol use disorder among people with epilepsy.
Conclusion and recommendation: The findings of this study revealed that the prevalence 
of alcohol use disorder among people with epilepsy was high. Routine screening of epileptic 
patients with the Alcohol Use Disorders Identification Test is recommended.
Keywords: alcohol use disorder, epilepsy, Amanuel Mental Specialized Hospital, sub-Saharan 
Africa, stress relief
Introduction
Epilepsy is a common chronic neurological disorder that affects nearly 70 million 
people worldwide.1 More than 85% of people with epilepsy are living in low- and 
middle-income countries including sub-Saharan Africa.2,3 Meta-analysis studies on 
the estimation of burden of epilepsy showed that the median lifetime prevalence for 
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epilepsy in developed countries was 5.8 per 1,000 population 
(2.7–12.4) compared with the 15.4 per 1,000 (4.8–49.6) for 
rural and 10.3 per 1,000 (2.8–37.7) for the urban population 
in developing countries.3,4
A systematic analysis study on the prevalence of epi-
lepsy in sub-Saharan Africa showed that active epilepsy 
was estimated to affect 4.4 million people, while lifetime 
epilepsy was estimated to affect 5.4 million.5 Another 
meta-analysis showed that the median incidence of epi-
lepsy was 50.4/100,000/year (33.6–75.6), while it was 
45.0 (30.3–66.7) for high-income countries and 81.7 
(28.0–239.5) for low- and middle-income countries.6 A huge 
treatment gap is suspected for epilepsy, and data suggest 
that nearly 80%–85% of people with epilepsy have never 
been diagnosed and treated. The existing studies suggest 
that there is a three- to fourfold increased risk of dying 
from epilepsy.7
A community-based study in 61,686 populations in a 
rural area of central Ethiopia showed that 139 incident case 
of epilepsy, corresponding to an annual incidence of 64 in 
100,000 people. The study showed that incidence of epilepsy 
is high in Ethiopia.8 Alcohol use disorders represent one of 
the leading causes of preventable death, illness, and injury 
in many societies throughout the world.9 Alcohol is a causal 
factor for 60 types of diseases and injuries and a component 
cause in 200 others. Almost 4% of all deaths worldwide are 
attributed to alcohol, greater than deaths caused by HIV/
AIDS, violence, or tuberculosis. Alcohol is also associated 
with many serious social issues, including violence, child 
neglect and abuse, and absenteeism in the workplace.10 
Overall, 4% of global burden of disease is attributable to 
alcohol.10,11 Alcohol abuse contributes to 4.6% global dis-
ability adjusted life years.12
The most dangerous complication of alcohol intoxication 
is respiratory depression.13 A blood level of 500 mg/dL is 
lethal in around 50% of patients, but when used with other 
central nervous system depressants like phenobarbital (anti-
epileptic drug), much lower blood levels can be fatal.13,14
Heavy alcohol consumption has multiple negative con-
sequences for people with epilepsy such as precipitation of 
seizure, exacerbation of seizure, worsening of seizure control, 
increased side effects of antiepileptic drugs, noncompliance 
to antiepileptic drugs, alcohol withdrawal seizures, long-term 
hospital admission, status epilepticus (9%–25%), sudden 
unexpected death, and premature mortality.12,15–17
Alcohol and epilepsy are completely interrelated. The 
seizure threshold is raised by alcohol drinking and declines 
on cessation of drinking. As a result, during withdrawal from 
alcohol, usually 6–8 hours after the cessation of drinking, 
seizures may occur.16 Although it is commonly perceived 
that patients with epilepsy experience problems with sei-
zure control if they use alcohol, this is not confirmed by 
the few experimental studies that have tested the hypoth-
esis. The mechanisms by which the long-term neurotoxic 
effects of alcohol lead to chronic epilepsy also need further 
studies.17,18
Alcohol-related withdrawal contributes to 26% and 9% of 
status epilepticus and refractory status epilepticus in adults, 
respectively.19 The relationship of alcoholism to epilepsy has 
been recognized for many years, but the role of alcohol in the 
exacerbation of primary epilepsy and in triggering seizures 
in epileptic patients is often not well recognized. Control of 
alcohol ingestion is an important factor in the management 
of epilepsy.20
Despite alcohol use disorders having severe, chronic, 
and fatal consequences in people with epilepsy, little is 
known about its prevalence and associated factors among 
people with epilepsy in Ethiopia. Therefore, this study was 
performed to determine prevalence of alcohol use disorders 
and associated factors among people with epilepsy attending 
Amanuel Mental Specialized Hospital. Also, this study was 
intended to fill this gap, and the findings of this study help 
to give special attention for those patients with epilepsy and 
alcohol use disorder.
Methods and materials
An institution-based cross sectional study was conducted at 
Amanuel Mental Specialized Hospital from April 15, 2014 
to May 15, 2014. Amanuel Mental Specialized Hospital is 
one of the oldest hospitals in Ethiopia. It was established in 
1930 by Italians to serve the nation of Ethiopia. It is located 
in western part of Addis Ababa in Addis ketema subcity 
kebele 08. The hospital has 259 beds including 11 private 
wing beds and 23 emergency beds. The hospital has 13 
outpatient departments. An average of 26,400 follow-up 
and new patients receive services annually, and most of the 
patients attend with family members. A total of 2,200 epi-
leptic patients are seen by neuropsychiatry case team each 
month, and it ranks second in outpatient department patient 
volume in the hospital.
All adult people with epilepsy attending Amanuel Mental 
Specialized Hospital were the source population, and those 
people with epilepsy who visited Amanuel Mental Special-
ized Hospital during the study period and fulfilled the inclu-
sion criteria were considered as study population. Participants 
aged 18 years and above were included in the study, and those 
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people who were unable to communicate and were seriously 
disturbed were excluded from the study.
The sample size was determined by using a single pro-
portion formula considering the following the assumption: 
standard normal distribution with confidence interval of 95% 
(Z=1.96), absolute precision or tolerable margin of error 
(d=0.05), since proportion of alcohol use disorder among 
people with epilepsy is unknown in Ethiopia (P=50%), and 
so taking 10% nonresponse rate, the final calculated sample 
size was 423.
Systematic random sampling method was used to select 
the study subjects. A total of 2,200 patients are seen at out-
patient department of Amanuel Mental Specialized Hospital 
per month, and the sampling interval was calculated by using 
the formula K=N/n=2,200/423=~5.2. The first patient was 
selected by lottery method and every fifth patient was selected 
until the sample number was reached.
Data were collected through face-to-face interview 
tech nique by using a structured questionnaire. The English 
questionnaire was translated to Amharic by an expert and 
adopted with minor modifications and was back-translated to 
English. Alcohol Use Disorders Identification Test (AUDIT), 
a 10 item tool, was used for assessing alcohol use. A struc-
tured questionnaire was used to assess sociodemographic 
and other independent variables.
A pretest was conducted on 21 subjects at Zewditu 
Memorial Hospital 1 week prior to the actual data collection 
and the appropriateness of the questionnaire checked by 
the investigator. Training was given for data collectors and 
supervisors before the data collection period. Completeness 
of the questionnaire was checked daily by supervisors.
Data were coded, entered, and cleaned by using EPI Info 
Version 7 and analyzed by using SPSS version 20 (IBM 
Corp., Armonk, NY, USA). Descriptions of variables were 
presented as frequencies, percentage, tables, and graphs. 
Bivariate and multivariate analyses were done to study the 
association, which was explained by P-value, odds ratio, and 
95% confidence interval. A P-value ,0.05 was considered 
as being statistically significant.
According to AUDIT, an individual whose score is 16 or 
more is said to have alcohol use disorder. Poor social sup-
port is defined as those who score 3–8 on the Oslo-3 Social 
Support Scale (OSSS-3). Moderate social support is defined 
as those who score 9–11 on OSSS-3. Strong social support 
includes those who score 12–14 on the OSSS-3. A patient 
is defined as “a current substance user” if he/she has used 
any of the following specified substances: cigarette, khat, 
cannabis, and cocaine in the past 3 months.
Ethical statement
Ethical clearance was obtained from the ethical review board 
of Institute of Public Health, College of Medicine and Health 
Sciences, University of Gondar and Amanuel Mental Special-
ized Hospital. The Institute of Public Health ethical review 
board approved the methods of data collection and forms of 
consent. Written informed consent was obtained from each 
participant. The objective of the study was explained to 
study subjects and the right was given for the study subjects 
to discontinue the interview at any time. Those who were 
considered as alcohol dependent by data collectors were 
referred to addiction case team for further evaluation and 
management. Confidentiality was maintained by not writing 
identification and name of the participants.
Results
A total of 423 study participants were selected, of whom 413 
completely filled the questionnaire, resulting in a response 
rate 97.6%.
Sociodemographic and related 
characteristics of the respondents
The age of respondents ranged from 18 to 78 years with a 
mean age of 31.9 (±SD 10.97) years. From the total respon-
dents, 137 (33.2%) were between 25 and 31 years of age. 
Of the participants, 248 (60%) were males, 272 (65.9%) 
were Orthodox Christians by religion, and 171 (41.4%) were 
Amhara by ethnicity. With regard to marital status, 223 (54%) 
of the participants were single. One hundred thirty seven 
(33.2%) of study participants had been educated to between 
grade 9 and 12. Majority (257 [62.2%]) of the participants 
were living with their family members (Table 1).
clinical factors of the respondents
Concerning the clinical factors, duration of illness ranges 
from less than 1 to 37 years with a mean duration of 9.91 
(±standard deviation [SD] 6.94) years. One hundred forty 
eight (35.8%) of the respondents had been ill for 6–10 years. 
Duration of treatment with antiepileptic drug also varied 
from treatment for less than 1 year to having been treated 
for 36 years, and the mean duration of treatment was 7.02 
(SD ±5.90) years. Of the total study subjects, 218 (52.8%) 
were treated with antiepileptic drug for less than 5 years. 
Three hundred forty eight (84%) of the respondents took 
phenobarbital and 319 (77.2%) took only one antiepileptic 
drug. For 90 (21.8%) patients, tella/tej was most preferred 
alcohol, and 107 (25.9%) patients stated that they drank for 
relaxation purpose (Table 2).





Table 1 Distribution of sociodemographic characteristics of 




18–24 years 108 26.2
25–31 years 137 33.2
32–38 years 79 19.1
39–45 years 48 11.6























grade 1–4 56 13.6
grade 5–8 44 10.6
grade 9–12 107 25.9
above grade 12 137 33.2
Occupational status
government employed 61 14.8
Private employed/merchant 119 28.8




living with family members 257 62.2
Not living with family members 156 37.8
Availability of own house
Yes 310 75.1
No 103 24.9
Notes: ahawariate; bWolaita, silte, Dawro; cjobless.
social support characteristics of the 
respondents
One hundred ninety five (47.2%) study participants stated 
that they have one or two persons who share their problems. 
Only 127 (30.8%) of participants reported that other people 
had a lot of concern about what they were feeling/doing. On 
the basis of the results of the OSSS-3, 260 (63%) had poor 
social support (score ,9 out of 14) (Table 3).
Table 2 clinical factors of people with epilepsy attending amanuel 
Mental specialized hospital, addis ababa, ethiopia (n=413)
Variables Category N %
Duration of illness ,5 years 134 32.4
6–10 years 148 35.8
.10 years 131 31.7
Treatment duration 
with aeD
,5 years 218 52.8
6–10 years 116 28.1
.10 years 79 19.1
Took phenobarbital Yes 348 84.3
No 65 15.7






Took carbamazepine Yes 47 11.4
No 366 88.6
Number of aeD 
currently taking
Only one aeD 319 77.2
More than one aeD 94 22.8
Most preferable type of 
alcohol he/she drinks
No specific preference 192 46.5
Tej or tella 90 21.8
areke/local alcohol 31 7.5
Beer/draft 68 16.5
Wine 12 2.9
Whisky or gin 20 4.8
reason for drinking 
alcohol
No specific reason 192 46.5
To socialize 70 16.9
Peer pressure 10 2.4
To relief from stress 34 8.3
To relax 107 25.9




Abbreviation: aeD, antiepileptic drug.
Table 3 social support characteristics of people with epilepsy 
attending amanuel Mental specialized hospital, addis ababa, 
ethiopia (n=413)
Variables Category N %
Number of people 
who share his/her 
problems
No person 57 13.8
1–2 persons 195 47.2
3–5 persons 114 27.6
.5 persons 47 11.4
Peoples concern 
about what the 
patient is doing
No concern 11 2.7
little concern 69 16.7
Uncertain 50 12.1
some concern 156 37.8
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history of substance use other than 
alcohol in the past 3 months
Among the respondents, 343 (83.1%) of them did not use 
any substance other than alcohol in the past 3 months. Sixty 
seven (16.2%) and 31 (7.5%) of the respondents reported the 
use of Khat and cannabis, respectively, in the past 3 months 
(Table 4).
Prevalence of alcohol use disorder
In this study, the prevalence of alcohol use disorder among peo-
ple with epilepsy was 72 (17.4%). On the AUDIT, 72 (17.4%) 
of the respondents scored above the cutoff point of 16. Male 
and female respondents who scored above the cutoff point of 
AUDIT were 46 (18.5%) and 26 (15.8%), respectively.
Factors associated with alcohol use 
disorder among people with epilepsy
During bivariate analysis, educational status, living condi-
tions, availability of own house, duration of illness, duration 
of treatment with antiepileptic drug, taking phenobarbital, 
taking carbamazepine, history of other substance use in the 
past 3 months, history of Khat chewing, type of alcohol-
containing beverage, reason for drinking alcohol, and family 
history of alcohol use were associated (P-value ,0.2) with 
alcohol use disorders among people with epilepsy.
After adjusted multiple logistic regression, educational 
status, living condition, availability of own house, taking 
carbamazepine, and reason for drinking alcohol were sig-
nificantly associated with alcohol use disorder among people 
with epilepsy.
Those participants who had studied to between grade 9 
and 12 were three times more likely to have alcohol use 
disorder (adjusted odds ratio [AOR] =3.25, [1.21, 8.69]) 
compared with those who had studied beyond grade 12. 
Those who did not live with family members were 1.89 times 
more likely to have alcohol use disorder (AOR =1.89, [1.06, 
3.39]) compared with those living with family members. 
Those participants who reported not having their own house 
were also two times more likely to have alcohol use disorder 
(AOR =2.04, [1.10, 3.78]) compared with those who have 
an own house.
Those respondents taking carbamazepine were two 
times more likely to have alcohol use disorder (AOR =2.38, 
[1.13, 5.01]) compared with those who were not taking 
carbamazepine. Those participants who drank alcohol to 
find relief from stress were four times more likely to have 
alcohol use disorder (AOR =4.28, [1.89, 9.67]) compared 
with those patients who had no specific reason for drinking 
alcohol (Table 5).
Table 4 history of substance other than alcohol in the past 
3 months among epilepsy patients attending amanuel Mental 
specialized hospital, addis ababa, ethiopia (n=413)
Variables Category N %
Use any substances other than  
alcohol in the past 3 months
Yes 70 16.9
No 343 83.1
Use cigarette Yes 61 14.8
No 352 85.2
Use khat Yes 67 16.2
No 346 83.8
Use cannabis Yes 31 7.5
No 382 92.5
Table 5 Bivariate and multivariate logistic regression analysis result of alcohol use disorder among people with epilepsy attending 
amanuel Mental specialized hospital, addis ababa, ethiopia (n=413)




Unable to read and write 44 12 2.86 (0.99, 8.21) 2.54 (0.83, 7.82)
grade 1–4 36 8 2.33 (0.75, 7.26) 1.56 (0.46, 5.33)
grade 5–8 90 17 1.98 (0.74, 5.31) 1.92 (0.67, 5.49)
grade 9–12 108 29 2.82 (1.11, 7.16) 3.25 (1.21, 8.69)*
above grade 12 63 6 1.00 1.00
current living 
conditions
living with family members 224 33 1.00 1.00
Not living with family members 117 39 2.26 (1.35, 3.79) 1.89 (1.06, 3.39)*
availability of 
own house
Yes 266 44 1.00 1.00
No 75 28 2.25 (1.32, 3.87) 2.04 (1.10, 3.78)*
Took 
carbamazepine
Yes 34 13 1.99 (0.99, 3.99) 2.38 (1.13, 5.01)*
No 307 59 1.00 1.00
reason for 
drinking alcohol
No specific reason 166 26 1.00 1.00
To socialize 56 14 1.59 (0.78, 3.27) 1.54 (0.77, 3.08)
Peer pressure 9 1 0.75 (0.08, 5.83) 0.54 (0.61, 4.75)
To find relief from stress 21 13 3.95 (1.77, 8.85) 4.28 (1.89, 9.67)*
To relax 89 18 1.29 (0.67, 2.48) 1.23 (0.61, 2.11)
Note: *P,0.05.
Abbreviations: AUDIT, Alcohol Use Disorders Identification Test; COR, crudes odds ratio; AOR, adjusted odds ratio; CI, confidence interval.






Alcohol use disorder has severe health consequences, 
especially in those people with epilepsy. The prevalence 
of alcohol use disorder was 17.4% among people with epi-
lepsy. In this study, the prevalence of alcohol use disorder 
among people with epilepsy was higher than that observed 
in the study done on epileptic outpatients (12%) but lower 
than that of inpatients (35%) in Norway.21,22 The differ-
ence might be due to AUDIT cutoff point and severity of 
illness. In the current study, a cutoff point of $16 on the 
AUDIT was used, whereas the Norwegian study used a 
cutoff point of $8.
Also, those epileptic patients treated in outpatient 
department of Amanuel Mental Specialized Hospital have 
relatively less severe illness compared with those patients 
in Norway. The reason for admission of epileptic patients 
might be alcohol-related complication, status epilepticus, 
alcohol withdrawal, or alcohol intoxication. This may be 
the reason for high prevalence of alcohol use disorder in 
admitted patients in Norway.
The prevalence of alcohol use disorder was lower 
compared with the study conducted on admitted epileptic 
patients in United States of America (41%).23 This variation 
might be due to cultural acceptance of drinking alcohol, 
accessibility of alcohol containing beverages, and severity 
of illness.
The proportions of unemployed, cannabis users, and 
those treated with a single antiepileptic drug were lower 
than that observed in the study done in South Africa.24 In 
this study, 17.2% were unemployed, 7.5% used cannabis, 
and 77.2% were treated with a single antiepileptic drug. 
A similar study done on 101 epileptic patients who were 
readmitted to Komani Hospital, South Africa, showed that 
63% were unemployed, 24% used cannabis, and 97% were 
on a single antiepileptic drug.24 This difference might be 
due to variation in inclusion criteria, severity of illness, 
accessibility of cannabis, and practice of rational use of 
antiepileptic drugs.
In South Africa, they assessed readmitted epileptic 
patients, whereas in our study only patients who were treated 
at outpatient department were included. Severity of illness 
may influence employment status of the patients in South 
Africa. A higher percentage of patients were on a single 
antiepileptic drug when compared with this study. These 
might be due to availability of highly qualified professionals 
and the application of standard treatment recommendations 
(monotherapy) for epileptic patients in Komani hospital, 
South Africa.24
Those participants whose educational status ranged from 
grade 9 to 12 were three times more likely to have alcohol 
use disorder (AOR =3.25, [1.21, 8.69]) compared with those 
who had studied above grade 12. This might be because grade 
9–12 is a critical time that determines the academic success 
and the future career of the students, and so, this is associ-
ated with increased academic stress. The students might also 
drink alcohol to find relief from stress.
Those who are not living with family members were 
1.89 times more likely to have alcohol use disorder 
(AOR =1.89, [1.06, 3.39]) compared with those living with 
family members. This may be due to freedom from parental 
control and also ability to make independent decisions in all 
aspect of his/her life.
Those participants reported not having their own 
house were also two times more likely to have alcohol 
use disorder (AOR =2.04, [1.10, 3.78]) compared with 
those who have reported having their own house. This 
may be because they may suffer more from different kinds 
of life stressors that lead to alcohol use as reliving factor 
for this stress.
Those respondents taking carbamazepine were two 
times more likely to have alcohol use disorder (AOR =2.38, 
[1.13, 5.01]) compared with those who were not taking 
carbamazepine. Alcohol may lower carbamazepine levels 
because of microsomal enzyme induction. Due to this factor, 
patients who take carbamazepine may drink alcohol more 
than other patients.
Those participants who drink alcohol to find relief from 
stress were four times more likely to have alcohol use disor-
der (AOR =4.28, [1.89, 9.67]) compared with those patients 
who drink alcohol for no specific reasons. This might be 
because people drink alcohol for relaxant and euphoric effects 
for a moment and to reduce stress, but this may worsen the 
stress in the long term.
Limitations of the study
Alcohol may cause epilepsy, and epileptic patients are also 
more vulnerable to use alcohol than the general population. 
But, it is difficult to distinguish the cause and effect relation-
ship using a cross-sectional study design. The type of epilepsy 
is not studied because clinicians do not clearly state the type 
of epilepsy during diagnosis in the patient chart.
Conclusion and recommendations
The prevalence of alcohol use disorder among people 
with epilepsy was high, which is a public health problem. 
Educational status, living condition, availability of own 
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house, taking carbamazepine, and drinking alcohol to find 
relief from stress were associated with alcohol use disorder 
among people with epilepsy.
Amanuel Mental Specialized Hospital has to work to 
improve assessment and management of alcohol use disorder 
among people with epilepsy. It will be better if clinicians 
do routine screening of epileptic patients with the AUDIT. 
During assessment of alcohol use disorder among epileptic 
patients, clinicians need to better focus on educational status, 
living conditions, availability of own house, consumption of 
carbamazepine, and reason of drinking alcohol (eg, to find 
relief from stress). Also, it would be better to make a note of 
the type of epilepsy in the patient chart. Finally, we recom-
mend other researchers to conduct better prospective studies 
to investigate potential risk factors of alcohol use disorder 
among patients with epilepsy.
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